---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-027058"
form_type: "8-K"
ticker: "DNA"
cik: "0001830214"
company_name: "Ginkgo Bioworks Holdings, Inc."
filed_at: "2025-05-21T23:59:59+00:00"
generated_at: "2026-05-20T22:44:02.584970+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Ginkgo CFO Dmytruk to resign May 30; CAO Coen appointed CFO

## Summary
- Mark Dmytruk resigns as CFO, effective May 30, 2025, to accept a position at another organization.
- Steven Coen, CAO, becomes CFO, principal financial officer, and principal accounting officer.
- Coen has 30+ years of experience, previously EVP & Corporate Controller at Charles River Labs, and audit at Deloitte.
- Coen's base salary is $460,000; he receives a PSU award of 67,991 shares tied to 2025 cash flow objectives.
- Coen joined Ginkgo in May 2023 and is a CPA in Massachusetts.

## SEC filing metadata
- accession: 0001628280-25-027058
- form_type: 8-K
- ticker: DNA
- cik: 0001830214
- company_name: Ginkgo Bioworks Holdings, Inc.
- filed_at: 2025-05-21T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1830214/000162828025027058/0001628280-25-027058-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1830214/000162828025027058/dna-20250519.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-027058
- JSON: https://secwatch.observer/filing/0001628280-25-027058.json
- Plain text: https://secwatch.observer/filing/0001628280-25-027058.txt

## Key facts
- Executive change
  Mark Dmytruk resigned as Chief Financial Officer at Ginkgo Bioworks Holdings, Inc..
  - Action: resigned
  - Role: Chief Financial Officer
  source text: Mark Dmytruk, the Company’s Chief Financial Officer and principal financial officer, gave notice on May 19, 2025 of his intention to resign from these roles at the Company on May 30, 2025 to accept a position at another organization
  evidence_url: https://www.sec.gov/Archives/edgar/data/1830214/000162828025027058/0001628280-25-027058-index.htm
- Executive change
  Steven Coen was appointed as Chief Financial Officer at Ginkgo Bioworks Holdings, Inc..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: Steven Coen, CPA, the Company’s Chief Accounting Officer, will become Chief Financial Officer, principal financial officer and principal accounting officer, effective upon Mr. Dmytruk’s resignation
  evidence_url: https://www.sec.gov/Archives/edgar/data/1830214/000162828025027058/0001628280-25-027058-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.